Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

777
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
777
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

582
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
582
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

804
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
804
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

334
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
334
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

598
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
598
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

446
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
446

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

UNICORN TAVR in Native Complex Congenital Aortic Stenosis at High Risk of Coronary Obstruction.

JACC. Case reports·2026
Same author

Infective Endocarditis Risk After Invasive Dental Procedures.

Mayo Clinic proceedings. Innovations, quality & outcomes·2025
Same author

[2025 ESC/EACTS Guidelines for the management of valvular heart disease].

Giornale italiano di cardiologia (2006)·2025
Same author

Dedicated Versus Conventional Devices in Patients With Pure Native Aortic Regurgitation: A Systematic Review and Meta-Analysis.

Journal of the American Heart Association·2025
Same author

Endocarditis Prophylaxis-Indications, Application and Current Controversies.

The Canadian journal of cardiology·2025
Same author

Aortic Valve Replacement in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
查看所有相关文章

相关实验视频

Updated: Apr 4, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K

感染性内心炎

Thomas J Cahill1, Bernard D Prendergast2

  • 1Department of Cardiology, Oxford University Hospitals, Oxford, UK.

Lancet (London, England)
|September 6, 2015
PubMed
概括
此摘要是机器生成的。

传染性内心炎是一种严重的心脏膜感染,病因有所变化,患者年龄较大. 尽管有进展,但死亡率仍然很高,强调需要更好的管理策略.

更多相关视频

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K
Isolation of Valvular Endothelial Cells
11:04

Isolation of Valvular Endothelial Cells

Published on: December 29, 2010

21.1K

相关实验视频

Last Updated: Apr 4, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K
Isolation of Valvular Endothelial Cells
11:04

Isolation of Valvular Endothelial Cells

Published on: December 29, 2010

21.1K

科学领域:

  • 心脏病学
  • 传染性疾病
  • 临床医学

背景情况:

  • 传染性内心炎 (IE) 是一种影响心脏门和心脏器件的全球性疾病.
  • 流行病学显示患者年龄和患病率在那些内置设备的人群中不断增加.
  • 微生物学已经发生了变化,

研究的目的:

  • 审查目前感染性内心炎的临床实践.
  • 讨论尚未解决的争议和新兴的疾病管理策略.
  • 突出感染性内心炎的持续高死亡率.

主要方法:

  • 关于传染性内心炎的最新文献的审查.
  • 对流行病学和微生物学的趋势进行分析.
  • 讨论诊断和治疗方面的进展.
  • 检查临床管理的挑战和争议.

主要成果:

  • 患者的平均年龄增加了一倍,心脏器械患者的发病率增加.
  • 感染性内心炎的主要病因已经取而代之.
  • 尽管有新的诊断和治疗方法, 一年死亡率仍然高达30%.

结论:

  • 传染性内心炎在流行病学和微生物学上提出了不断变化的挑战.
  • 死亡率仍然很高,强调需要改进管理策略.
  • 解决后勤障碍和争议对于改善患者治疗结果至关重要.